Duloxetine for treating painful neuropathy or chronic pain

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Lunn, Michael P T ^a   Hughes, R A C ^b   Wiffen, P J ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; PLACEBO;

CHRONIC PAIN; CLINICAL TRIAL; DATA EXTRACTION; DATA SYNTHESIS; DRUG FORMULATION; ECONOMIC ASPECT; HUMAN; INFORMATION PROCESSING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 44949124697     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007115     Document Type: Review

References (17)

1. Annane 2007 Annane D, Barton R, Cornblath DD, Fernandes J, Gunn A, Hughes RAC, et al.Neuromuscular Disease Group in About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). The Cochrane Library 2007, issue Issue 2.Art.No. NEUROMUSC.
2. Aronson 2006 Aronson JK, Dukes MN. Meyler's side effects of drugs. 15th Edition. Amsterdam: Elsevier, 2006.
3. Breivik 2006 Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain 2006;10(4):287-333.
4. Bymaster 2001 Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, et al.Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001;25(6):871-80.
5. Bymaster 2005 Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Current Pharmaceutical Design 2005;11(12):1475-93.
6. Daousi 2004 Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabetic Medicine 2004;21(9):976-82.
7. Elbourne 2002 Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
8. Gahimer 2007 Gahimer J, Wernicke J, Yalcin I, Ossanna MJ, Wulster-Radcliffe M, Viktrup L. A retrospective polled analysis of duloxetine safety in 23,983 subjects. Current Medical Research Opinion 2007;23(1):175-184.
9. Hall 2006 Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122(1-2):156-62.
10. Mariappan 2005 Mariappan P, Ballantyne Z, N'Dow JMO, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews 2007, Issue 3.Art. No.: CD004742. DOI:10.1002/14651858.CD004742.pub2.
11. Nagda 2004 Nagda J, Bajwa ZH. Definitions and Classification of Pain. Principles and practice of pain management. New York: McGraw Hill, 2004:51-4.
12. Nose 2007 Nose M, Cipriani A, Furukawa TA, Omori I, Churchill R, McGuire H et al for the Meta-Analysis of New Generation Antidepressants (MANGA) Study Group. Duloxetine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews 2007, Issue 2.Art.No.: CD006533. DOI:10.1002/14651858.CD006533.
13. Perahia 2006 Perahia DG, Pritchett YL, Desaiah D, Raskin J. Efficacy of duloxetine in painful symptoms: analgesic or antidepressant effect?. International Clinical Psychopharmacology 2006;21(6):311-7.
14. Saarto 2005 Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD005454. DOI:10.1002/14651858.CD005454.pub2.
15. Schuessler 2006 Scheussler B. What do we know about duloxetine's mode of action? Evidence from animals to humans. British Journal of Obstetrics and Gynaecology 2006;113 Suppl 1:5-9.
16. Treede 2007 Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al.Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2007;in press.
17. Wiffen 2005 Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art.No.: CD005452. DOI:10.1002/14651858.CD005452.